Funds › Simplify Asset Management Inc.
Simplify Asset Management Inc.
13F for Q3 2026, filed Oct 27, 2026. 111 positions worth $6.1B.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Latest report
Q3 2026
filed Oct 27, 2026
Reported value
$6.1B
−$1.1B (15.0%) vs Q2 2026
Positions
111
136 in Q2 2026
Top 10 share
89.3%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Simplify Asset Management Inc. in the latest 13F quarter?
Using 13F.ai, how has Simplify Asset Management Inc.'s portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Simplify Asset Management Inc.'s top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | Simplify Exchange Traded Fun Govt Mone Ma Etf | 39.75M | $4.0B | 65.1% | -19.1% | 13F ↗ |
| 2 | iShares Tr Core S&P500 Etf | 1.02M | $780.1M | 12.8% | -2.3% | 13F ↗ |
| 3 | iShares Tr Core Us Aggbd Et | 4.71M | $445.3M | 7.3% | -6.6% | 13F ↗ |
| 4 | Simplify Exchange Traded Fun Multi Qis Altern | 4.48M | $48.1M | 0.8% | +18.5% | 13F ↗ |
| 5 | Simplify Exchange Traded Fun Us Equi Plus Etf | 1.50M | $44.0M | 0.7% | +1400% | 13F ↗ |
| 6 | Simplify Exchange Traded Fun Natl Muni Bd Etf | 1.55M | $35.9M | 0.6% | Unchanged | 13F ↗ |
| 7 | LLY Eli Lilly and Company | 30,088 | $34.8M | 0.6% | +104% | 13F ↗ |
| 8 | PAGP Plains GP Holdings, L.P. · Ltd Partnr Int A | 1.27M | $33.0M | 0.5% | Unchanged | 13F ↗ |
| 9 | Simplify Exchange Traded Fun Targe 15 Etf | 1.15M | $27.7M | 0.5% | +84.1% | 13F ↗ |
| 10 | Simplify Exchange Traded Fun | 559,812 | $27.2M | 0.4% | -65.8% | 13F ↗ |
| 11 | HUM Humana Inc. | 65,190 | $24.9M | 0.4% | New | 13F ↗ |
| 12 | ARQT Arcutis Biotherapeutics, Inc. | 865,862 | $22.9M | 0.4% | New | 13F ↗ |
| 13 | Simplify Exchange Traded Fun Treasury Opt Inc | 975,000 | $22.5M | 0.4% | -42.6% | 13F ↗ |
| 14 | WRBY Warby Parker Inc. | 627,337 | $17.4M | 0.3% | +6.9% | 13F ↗ |
| 15 | IBIT iShares Bitcoin Trust ETF · Shs Ben Int | 357,300 | $16.9M | 0.3% | -26.6% | 13F ↗ |
| 16 | ABBV AbbVie Inc. | 64,262 | $16.8M | 0.3% | -0.3% | 13F ↗ |
| 17 | JNJ Johnson & Johnson | 62,457 | $16.5M | 0.3% | -14.3% | 13F ↗ |
| 18 | TMO Thermo Fisher Scientific Inc | 24,130 | $16.3M | 0.3% | +4.6% | 13F ↗ |
| 19 | UNH UnitedHealth Group Incorporated | 41,403 | $15.2M | 0.2% | -1.9% | 13F ↗ |
| 20 | PCT PureCycle Technologies, Inc. | 3.33M | $14.7M | 0.2% | +9.1% | 13F ↗ |
| 21 | AVTR Avantor, Inc. | 965,919 | $14.5M | 0.2% | New | 13F ↗ |
| 22 | JAZZ Jazz Pharmaceuticals plc | 53,790 | $12.5M | 0.2% | -21.5% | 13F ↗ |
| 23 | Simplify Exchange Traded Fun Aggregate Bd Etf | 651,127 | $12.3M | 0.2% | -69.1% | 13F ↗ |
| 24 | GILD Gilead Sciences, Inc. | 81,061 | $12.1M | 0.2% | -0.3% | 13F ↗ |
| 25 | DGX Quest Diagnostics Incorporated | 49,538 | $11.5M | 0.2% | -0.4% | 13F ↗ |
| 26 | BNTC Benitec Biopharma Inc. | 1.00M | $10.0M | 0.2% | -0.3% | 13F ↗ |
| 27 | Simplify Exchange Traded Fun China A Shs Plus | 428,078 | $10.0M | 0.2% | Unchanged | 13F ↗ |
| 28 | AMGN Amgen Inc. | 20,917 | $8.8M | 0.1% | -0.3% | 13F ↗ |
| 29 | GH Guardant Health, Inc. | 48,940 | $8.7M | 0.1% | +77.5% | 13F ↗ |
| 30 | UTHR United Therapeutics Corporation | 16,084 | $8.7M | 0.1% | -64.6% | 13F ↗ |
| 31 | SMMT Summit Therapeutics Inc. | 510,106 | $8.6M | 0.1% | New | 13F ↗ |
| 32 | ACHV Achieve Life Sciences, Inc. | 932,105 | $7.5M | 0.1% | -34.9% | 13F ↗ |
| 33 | BHVN Biohaven Ltd. | 550,693 | $7.4M | 0.1% | -47.1% | 13F ↗ |
| 34 | TXG 10x Genomics, Inc. | 68,239 | $6.2M | 0.1% | -76.7% | 13F ↗ |
| 35 | GRAL GRAIL, Inc. | 42,969 | $6.0M | 0.1% | New | 13F ↗ |
| 36 | CVS CVS Health Corporation | 69,933 | $6.0M | 0.1% | -1.6% | 13F ↗ |
| 37 | CAH Cardinal Health, Inc. | 26,830 | $6.0M | 0.1% | -0.3% | 13F ↗ |
| 38 | VRTX Vertex Pharmaceuticals Incorporated | 10,428 | $5.5M | 0.1% | -0.3% | 13F ↗ |
| 39 | HODL VanEck Bitcoin Trust · Sh Ben Int | 175,843 | $4.2M | 0.1% | -33.5% | 13F ↗ |
| 40 | ESTA Establishment Labs Holdings Inc. | 60,333 | $3.9M | 0.1% | -0.3% | 13F ↗ |
| 41 | DCTH Delcath Systems, Inc. | 227,679 | $3.6M | 0.1% | -14.0% | 13F ↗ |
| 42 | TSLA Tesla, Inc. | 10,165 | $3.6M | 0.1% | -4.3% | 13F ↗ |
| 43 | Simplify Exchange Traded Fun Next Intangible | 97,303 | $3.5M | 0.1% | -88.2% | 13F ↗ |
| 44 | GEHC GE HealthCare Technologies Inc. | 51,877 | $3.4M | 0.1% | -0.3% | 13F ↗ |
| 45 | HSIC Henry Schein, Inc. | 37,999 | $3.2M | 0.1% | New | 13F ↗ |
| 46 | Simplify Exchange Traded Fun Pipe Sand Sm Etf | 91,464 | $3.0M | <0.1% | Unchanged | 13F ↗ |
| 47 | MIST Milestone Pharmaceuticals Inc. | 3.35M | $2.9M | <0.1% | Unchanged | 13F ↗ |
| 48 | ELV Elevance Health, Inc. | 7,316 | $2.8M | <0.1% | -71.4% | 13F ↗ |
| 49 | Simplify Exchange Traded Fun Ancorato Target | 116,500 | $2.7M | <0.1% | Unchanged | 13F ↗ |
| 50 | CORT Corcept Therapeutics Incorporated | 20,568 | $2.4M | <0.1% | -22.2% | 13F ↗ |
Showing the top 50 of 111 positions. Premium lists every position, plus puts and calls.
Changes since Q2 2026
13 new, 10 added to, 71 trimmed, 38 exited, 17 unchanged. By estimated dollars.
New positions (13)
| HUM Humana Inc. | 65,190 | New | $24.9M |
| ARQT Arcutis Biotherapeutics, Inc. | 865,862 | New | $22.9M |
| AVTR Avantor, Inc. | 965,919 | New | $14.5M |
| SMMT Summit Therapeutics Inc. | 510,106 | New | $8.6M |
| GRAL GRAIL, Inc. | 42,969 | New | $6.0M |
| HSIC Henry Schein, Inc. | 37,999 | New | $3.2M |
| COLL Collegium Pharmaceutical, Inc. | 93,521 | New | $2.0M |
| Simplify Exchange Traded Fun Taxaware Div Inc | 75,000 | New | $1.8M |
| CABA Cabaletta Bio, Inc. | 556,235 | New | $1.1M |
| PROK ProKidney Corp. | 483,741 | New | $803.0K |
Added to (10)
| Simplify Exchange Traded Fun Us Equi Plus Etf | 1.50M | +1400% | $41.1M |
| LLY Eli Lilly and Company | 30,088 | +104% | $17.8M |
| Simplify Exchange Traded Fun Targe 15 Etf | 1.15M | +84.1% | $12.7M |
| Simplify Exchange Traded Fun Multi Qis Altern | 4.48M | +18.5% | $7.5M |
| GH Guardant Health, Inc. | 48,940 | +77.5% | $3.8M |
| PCT PureCycle Technologies, Inc. | 3.33M | +9.1% | $1.2M |
| WRBY Warby Parker Inc. | 627,337 | +6.9% | $1.1M |
| BHR Braemar Hotels & Resorts Inc. · Reit | 653,000 | +257% | $784.9K |
| TMO Thermo Fisher Scientific Inc | 24,130 | +4.6% | $709.5K |
| FLL Full House Resorts, Inc. | 607,500 | +53.0% | $298.9K |
Trimmed (71)
| Simplify Exchange Traded Fun Govt Mone Ma Etf | 39.75M | -19.1% | -$939.9M |
| Simplify Exchange Traded Fun Short Term Trea | 23,740 | -99.5% | -$91.1M |
| Simplify Exchange Traded Fun | 559,812 | -65.8% | -$52.1M |
| iShares Tr Core Us Aggbd Et | 4.71M | -6.6% | -$31.4M |
| Simplify Exchange Traded Fun Aggregate Bd Etf | 651,127 | -69.1% | -$27.6M |
| Simplify Exchange Traded Fun Next Intangible | 97,303 | -88.2% | -$26.0M |
| TXG 10x Genomics, Inc. | 68,239 | -76.7% | -$20.3M |
| iShares Tr Core S&P500 Etf | 1.02M | -2.3% | -$18.4M |
| Simplify Exchange Traded Fun Treasury Opt Inc | 975,000 | -42.6% | -$16.7M |
| UTHR United Therapeutics Corporation | 16,084 | -64.6% | -$15.9M |
Exited (38)
| NVO Novo Nordisk A/S · ADR | 504,918 | Exited | -$24.2M |
| ALGN Align Technology, Inc. | 66,847 | Exited | -$11.3M |
| AZN AstraZeneca PLC | 34,188 | Exited | -$6.5M |
| EYPT EyePoint, Inc. | 400,044 | Exited | -$5.7M |
| ISRG Intuitive Surgical, Inc. | 7,492 | Exited | -$3.0M |
| ZVRA Zevra Therapeutics, Inc. | 70,759 | Exited | -$1.0M |
| OWL Blue Owl Capital Inc. | 106,500 | Exited | -$931.9K |
| MRK Merck & Company, Inc. | 7,167 | Exited | -$921.0K |
| Exxon Mobil Corp | 5,386 | Exited | -$736.4K |
| CIM Chimera Investment Corporation | 51,025 | Exited | -$680.7K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Any two quarters side by side. Part of Premium.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Oct 27, 2026 | 13F-HR | 115 | $6.1B | Current | SEC ↗ |
| Q2 2026 | Jul 16, 2026 | 13F-HR | 141 | $7.2B | Current | SEC ↗ |
| Q1 2026 | Apr 27, 2026 | 13F-HR | 143 | $6.5B | Current | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | 13F-HR | 142 | $6.1B | Current | SEC ↗ |
| Q3 2025 | Oct 20, 2025 | 13F-HR | 129 | $5.4B | Current | SEC ↗ |
| Q2 2025 | Aug 7, 2025 | 13F-HR | 89 | $2.0B | Current | SEC ↗ |
| Q1 2025 | May 13, 2025 | 13F-HR | 94 | $2.7B | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer